BeiGene (HKG:6160, SHA:688235) forecasts it will attain "positive operating income" for full-year 2025 in accordance with US generally accepted accounting principles, according to a Tuesday filing with the Hong Kong exchange.
Shares rose 4% in Hong Kong and 4% in Shanghai during Tuesday's morning trading.
Price (HKD): $112.80, Change: $+6.2, Percent Change: +5.82%